Related Experiment Videos
Preprotachykinin A gene expression after administration of 3,4-methylene dioxymethamphetamine (Ecstasy)
Pierluigi Pompei1, Elena Cavazzuti, Daniele Martarelli
1Department of Pharmacological Sciences and Experimental Medicine, University of Camerino, Via Scalzino 3, 62032 Camerino (MC), Italy. pete.pompei@unicam.it
Abstract:
This study tested the effects of 8 days of subchronic administration of 3,4-methylene dioxymethamphetamine (MDMA) (5 mg/kg b.w.) on preprotachykinin A mRNA levels in discrete rat brain regions. In situ hybridization examined preprotachykinin A mRNA levels in the core and shell of the nucleus accumbens, the islands of Calleja, the olfactory tubercle, the dorsal and ventral caudate-putamen, the bed nucleus of the stria terminalis, the medial preoptic area, the medial habenular nucleus and in the postero-dorsal part of the medial amygdala. Higher levels of preprotachykinin A mRNA were found in the core and shell of the nucleus accumbens, in the islands of calleja, in the olfactory tubercle, in the bed nucleus of the stria terminalis, in the medial habenular nucleus and the postero-dorsal part of the medial amygdala, compared to control animals. Conversely, increased preprotachykinin A mRNA levels were observed in the dorsal and ventral caudate-putamen in MDMA treated when compared to control rats. In the social memory test, MDMA significantly impaired rats' short-term working memory. These results show that chronic exposure to MDMA strongly affects preprotachykinin A mRNA levels in discrete rat brain regions. These changes occur in experimental conditions in which working memory is markedly reduced, suggesting that changes in gene expression of tachykinin mechanisms may contribute to the effects of MDMA on memory function.
Insights
Subchronic 3,4-methylene dioxymethamphetamine (MDMA) exposure altered preprotachykinin A mRNA levels in multiple rat brain regions. These changes correlated with significant impairments in working memory, suggesting a role in MDMA
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- 3,4-methylene dioxymethamphetamine (MDMA) is a psychoactive drug with known effects on neurotransmitter systems.
- Tachykinins, including substance P, are involved in various neurological processes, including memory and learning.
- Understanding MDMA's impact on gene expression in specific brain regions is crucial for elucidating its neurobiological effects.
Purpose of the Study:
- To investigate the effects of subchronic MDMA administration on preprotachykinin A mRNA expression in distinct rat brain areas.
- To determine the relationship between MDMA-induced changes in preprotachykinin A mRNA levels and working memory performance.
Main Methods:
- Rats received daily injections of MDMA (5 mg/kg) for 8 days.
- In situ hybridization was used to quantify preprotachykinin A mRNA levels in various brain regions, including the nucleus accumbens, caudate-putamen, and amygdala.
- A social memory test was employed to assess working memory function.
Main Results:
- MDMA administration led to increased preprotachykinin A mRNA levels in several brain regions, including the nucleus accumbens core/shell, olfactory tubercle, and medial amygdala.
- Conversely, preprotachykinin A mRNA levels were elevated in the dorsal and ventral caudate-putamen.
- MDMA significantly impaired short-term working memory in the social memory test.
Conclusions:
- Subchronic MDMA exposure significantly alters preprotachykinin A mRNA expression in a region-specific manner in the rat brain.
- The observed changes in tachykinin gene expression may contribute to the cognitive deficits, particularly working memory impairments, induced by MDMA.
- These findings highlight the complex neurobiological adaptations following MDMA exposure and their potential link to memory dysfunction.